New Search

Item 1 of 1 (back to results)

astromicin
An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms.


Current search:

03. Biological Effects of Specific Chemicals: biochemical uses [CHEBI:52206] > metabolite [CHEBI:25212] > secondary metabolite [CHEBI:26619] > astromicin [CHEBI:37923]
×

Select any link to see items in a related category.

more general categories    information about this item
03. Biological Effects of Specific Chemicals 
03. Biological Effects of Specific Chemicals
 biochemical uses [CHEBI:52206] (3306) 
 metabolite [CHEBI:25212] (2692) 
 secondary metabolite [CHEBI:26619] (2225) 
 astromicin [CHEBI:37923] (1)
 antimicrobial agent [CHEBI:33281] (927) 
 antibacterial agent [CHEBI:33282] (317) 
 astromicin [CHEBI:37923] (1)
08. Chemical Category 
08. Chemical Category
 main group molecular entity [CHEBI:33579] (25650) 
 s-block molecular entity [CHEBI:33674] (7287) 
 hydrogen molecular entity [CHEBI:33608] (6932) 
 hydroxides [CHEBI:24651] (5641) 
 organic hydroxy compound [CHEBI:33822] (3050) 
 polyol [CHEBI:26191] (437) 
 cyclitol [CHEBI:23451] (149) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 diol [CHEBI:23824] (172) 
 astromicin [CHEBI:37923] (1)
 p-block molecular entity [CHEBI:33675] (25343) 
 pnictogen molecular entity [CHEBI:33302] (10027) 
 nitrogen molecular entity [CHEBI:51143] (7930) 
 amide [CHEBI:32988] (1863) 
 primary amide [CHEBI:33256] (1586) 
 carboxamide [CHEBI:37622] (1381) 
 astromicin [CHEBI:37923] (1)
 organonitrogen compound [CHEBI:35352] (6705) 
 carboxamide [CHEBI:37622] (1381) 
 astromicin [CHEBI:37923] (1)
 organic amino compound [CHEBI:50047] (2472) 
 primary amino compound [CHEBI:50994] (104) 
 astromicin [CHEBI:37923] (1)
 chalcogen molecular entity [CHEBI:33304] (15225) 
 oxygen molecular entity [CHEBI:25806] (14414) 
 hydroxides [CHEBI:24651] (5641) 
 organic hydroxy compound [CHEBI:33822] (3050) 
 polyol [CHEBI:26191] (437) 
 cyclitol [CHEBI:23451] (149) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 diol [CHEBI:23824] (172) 
 astromicin [CHEBI:37923] (1)
 organooxygen compound [CHEBI:36963] (11352) 
 carboxamide [CHEBI:37622] (1381) 
 astromicin [CHEBI:37923] (1)
 glycosyl compound [CHEBI:63161] (1006) 
 glycoside [CHEBI:24400] (633) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 aminoglycoside [CHEBI:47779] (66) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 carbohydrate derivative [CHEBI:63299] (2582) 
 carbohydrate-containing antibiotic [CHEBI:23007] (58) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 aminoglycoside [CHEBI:47779] (66) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 organochalcogen compound [CHEBI:36962] (11874) 
 organooxygen compound [CHEBI:36963] (11352) 
 carboxamide [CHEBI:37622] (1381) 
 astromicin [CHEBI:37923] (1)
 glycosyl compound [CHEBI:63161] (1006) 
 glycoside [CHEBI:24400] (633) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 aminoglycoside [CHEBI:47779] (66) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 carbohydrate derivative [CHEBI:63299] (2582) 
 carbohydrate-containing antibiotic [CHEBI:23007] (58) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 aminoglycoside [CHEBI:47779] (66) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 carbon group molecular entity [CHEBI:33582] (23847) 
 organic molecular entity [CHEBI:50860] (23769) 
 heteroorganic entity [CHEBI:33285] (15197) 
 organonitrogen compound [CHEBI:35352] (6705) 
 carboxamide [CHEBI:37622] (1381) 
 astromicin [CHEBI:37923] (1)
 organic amino compound [CHEBI:50047] (2472) 
 primary amino compound [CHEBI:50994] (104) 
 astromicin [CHEBI:37923] (1)
 organochalcogen compound [CHEBI:36962] (11874) 
 organooxygen compound [CHEBI:36963] (11352) 
 carboxamide [CHEBI:37622] (1381) 
 astromicin [CHEBI:37923] (1)
 glycosyl compound [CHEBI:63161] (1006) 
 glycoside [CHEBI:24400] (633) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 aminoglycoside [CHEBI:47779] (66) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 carbohydrate derivative [CHEBI:63299] (2582) 
 carbohydrate-containing antibiotic [CHEBI:23007] (58) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 aminoglycoside [CHEBI:47779] (66) 
 aminoglycoside antibiotic [CHEBI:22507] (45) 
 astromicin [CHEBI:37923] (1)
 organic hydroxy compound [CHEBI:33822] (3050) 
 polyol [CHEBI:26191] (437) 
 cyclitol [CHEBI:23451] (149) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 diol [CHEBI:23824] (172) 
 astromicin [CHEBI:37923] (1)
 organic amino compound [CHEBI:50047] (2472) 
 primary amino compound [CHEBI:50994] (104) 
 astromicin [CHEBI:37923] (1)
 polyatomic entity [CHEBI:36357] (18777) 
 heteroatomic molecular entity [CHEBI:37577] (13672) 
 hydroxides [CHEBI:24651] (5641) 
 organic hydroxy compound [CHEBI:33822] (3050) 
 polyol [CHEBI:26191] (437) 
 cyclitol [CHEBI:23451] (149) 
 amino cyclitol glycoside [CHEBI:22479] (53) 
 astromicin [CHEBI:37923] (1)
 diol [CHEBI:23824] (172) 
 astromicin [CHEBI:37923] (1)
ChEBI Compound Accession Identifier  [CHEBI:37923]
ChEBI Compound Description  An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms.
ChEBI Compound Identification Number  37923
ChEBI InChI Value  InChI=1S/C17H35N5O6/c1-7(19)9-5-4-8(20)17(27-9)28-15-11(21)13(24)16(26-3)12(14(15)25)22(2)10(23)6-18/h7-9,11-17,24-25H,4-6,18-21H2,1-3H3/t7-,8+,9-,11-,12-,13-,14+,15+,16+,17+/m0/s1
ChEBI InChIKey Value  BIDUPMYXGFNAEJ-APGVDKLISA-N
ChEBI Compound Name  astromicin
ChEBI SMILES Value  [H][C@]1(CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)[C@H](O)[C@H](OC)[C@H]([C@H]2O)N(C)C(=O)CN)O1)[C@H](C)N
ChEBI Substance ID  160709398
ChEBI URL  ChEBI:37923
ChemSpider ID  NS
Ontomatica Chemical Accession Key (OnChAKey)  BIDUPMYXGFNAEJ_APGVDKLISA_N_000_000000
PubChem Compound ID  5284517